BioAge Labs Upsizes Proposed IPO to 10.5M Shares at $17-$19/sh

Forex Товарний ринок Фондовий ринок Криптовалюта

BioAge Labs Upsizes Proposed IPO to 10.5M Shares at $17-$19/sh

BioAge Labs (BIOA) has filed for an upsized 10,500,000 share IPO at $17-$19 per share. The company previously indicated a 7.5M share offering in the same price range.

Source: Investing.com

Останні публікації

Google: Signs that enterprise adoption of AI Is inflecting, says JMP Securities

25.09.2024 - 16:00

UniCredit overtures hold few fears for Germany's Mittelstand

25.09.2024 - 16:00

Hewlett Packard Enterprise upgraded to "Overweight" by Barclays

25.09.2024 - 16:00

Obesity drug developer BioAge Labs aims up to $640 million valuation in upsized US IPO

25.09.2024 - 16:00

US holiday spending on buy now, pay later to hit record due to debt-laden shoppers

25.09.2024 - 16:00

Earnings call: Stitch Fix reports FY 2024 results, projects FY 2026 growth

25.09.2024 - 16:00

Stellantis to lay off hundreds of workers in Michigan and Poland amid market shift

25.09.2024 - 16:00

Google complains to EU over Microsoft cloud practices

25.09.2024 - 16:00

Earnings call: Altamira Therapeutics focuses on RNA delivery growth

25.09.2024 - 16:00

Earnings call: Smiths Group Plc sees strong FY '24, targets growth in FY '25

25.09.2024 - 16:00

Buffett's Berkshire Hathaway offloads more shares in Bank of America

25.09.2024 - 16:00

Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.61%

25.09.2024 - 16:00

Piper Sandler downgrades Tyson Foods to Underweight, says growing risks not priced in

25.09.2024 - 16:00

Exclusive: FinWise announces strategic partnership with digital lender PowerPay

25.09.2024 - 15:00

Morgan Stanley cuts auto industry view to neutral, downgrades GM, Ford and Rivian

25.09.2024 - 15:00

© Analytic DC. All Rights Reserved.

Аналіз ринку Комплексний аналіз пари USDJPY

Ласкаво просимо в чат підтримки!